COVID-19 drug lead treatments identified
An international team of researchers has tested more than 10,000 compounds to identify six drug candidates that may help treat COVID-19.
The research, involving University of Queensland scientist Professor Luke Guddat, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.
“Currently there are no targeted therapeutics or effective treatment options for COVID-19,” Professor Guddat said.
“In order to rapidly discover lead compounds for clinical use, we initiated a program of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus.
Professor Guddat said the project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication.
“This makes it an attractive drug target for this virus, and as people don’t naturally have this enzyme, compounds that target it are likely to have low toxicity.
“We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus.
“If the amount is small, then we have a promising compound for further studies.”
After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.
“We’re particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer,” Professor Guddat said.
“Compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.”
After the enzyme’s structure was made public, the team received more than 300 requests for more information, even before the paper was published.
“To provide an analogy, we’ve provided scientists with a fishing pole, the line and the exact bait, and have in only one month caught some fish,” Professor Guddat said.
“Now it’s up to us and the other fisherman – our fellow scientists globally – to take full advantage of this breakthrough.”
“With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future.”
The international collaboration was led by researchers at ShanghaiTech University.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19 treatment
- Covid-19 vaccines face a trust gap against some traditional African remedieson March 1, 2021 at 5:37 pm
Zimbabwe and Madagascar backed home remedies in the early days of the pandemic. Now that could hinder vaccination efforts.
- New York Covid-19 Variant Expands Reach in U.S. With 735 Caseson March 1, 2021 at 5:34 pm
About 735 cases of a coronavirus variant that emerged in New York City in November have now been identified in the U.S., including 585 in the last two weeks, a federal health official said.
- COVID-19 ‘a perfect time’ for psychedelic drug therapy: treatment centreon March 1, 2021 at 5:29 pm
As the COVID-19 pandemic heads into its second year, mental health is a growing concern for many Canadians. A new centre in Calgary says treatment with psychedelic drugs could bring some relief. Gil ...
- ‘Miracle Mom’ COVID-19 survivor thanks 8 On Your Side after insurance issues are resolvedon March 1, 2021 at 5:10 pm
News Channel 8 first introduced you to the “Miracle Mom” in May 2020, after she beat the odds and survived COVID-19. She was the poster child of a patient who shouldn’t have made ...
- Reports: Trump, Melania received COVID-19 vaccine at White House in Januaryon March 1, 2021 at 5:09 pm
A Trump adviser told news outlets that the former president and first lady received coronavirus vaccines before leaving office on Jan. 20.
Go deeper with Google Headlines on:
COVID-19 treatment
Go deeper with Bing News on:
COVID-19
- New York Covid-19 Variant Expands Reach in U.S. With 735 Caseson March 1, 2021 at 5:34 pm
About 735 cases of a coronavirus variant that emerged in New York City in November have now been identified in the U.S., including 585 in the last two weeks, a federal health official said.
- Clover Health Hit By Rising Covid-19 Costs In Fourth Quarteron March 1, 2021 at 5:24 pm
The Medicare Advantage insurer is looking to expand into direct contracting as a way to boost its business in 2021, but is waiting for federal approval.
- J&J vaccine rolls out after CDC thumbs-up; US reports 306 variant cases, a daily record; 2.5M global deaths: Latest COVID-19 updateson March 1, 2021 at 5:05 pm
An advisory committee to the CDC voted unanimously to recommend the Johnson & Johnson COVID-19 vaccine on Sunday.
- US travel restrictions state by state during Covid-19on March 1, 2021 at 4:59 pm
For those of you planning a trip outside of your home state during the Covid-19 pandemic, CNN Travel has put together a US travel guide so you know what you're in for before you go.
- Covid-19 Live Updates: The U.S. Is Edging Toward Normal, Alarming Some Officialson March 1, 2021 at 4:45 pm
A single dose of the AstraZeneca vaccine can protect older people, a study shows. California reaches a deal that encourages schools to reopen.